Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-TRC-14004896Phase 4Recruiting
Phase 4, open-label trial of dexmedetomidine in abdominal malignancy (2 arms), sponsored by Shandong Cancer Hospital. Primary endpoints: Visual analog score, FOXP3 and 3 more. Started Jul 2014; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-TRC-14004896.